Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Adult - Adolescent

Terms

78Adult
62Adolescent
51Middle Aged
62Child
41Child, Preschool
33Infant
33Aged
68Male

Associations

Freq.WeightAssociation
5151Adolescent - Adult
4747Adult - Middle Aged
4040Adolescent - Child
3838Adolescent - Middle Aged
3737Child - Child, Preschool
3535Adult - Child
3232Adolescent - Child, Preschool
2929Child, Preschool - Infant
2828Child - Infant
2828Adult - Child, Preschool
2626Aged - Middle Aged
2626Adolescent - Infant
2525Child - Middle Aged
2525Adult - Male
2525Adult - Aged
2222Child, Preschool - Middle Aged
2222Adult - Infant
2121Male - Middle Aged
2121Adolescent - Aged
2020Adolescent - Male
1919Aged - Child
1818Infant - Middle Aged
1818Aged - Child, Preschool
1515Child - Male
1515Aged - Infant
1212Aged - Male
99Child, Preschool - Male

Documents par ordre de pertinence
000166 (2018) Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik PeirisPopulation Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
000A04 (2012) Tom Reichert [États-Unis] ; Gerardo Chowell [États-Unis] ; Jonathan A. Mccullers [États-Unis]The age distribution of mortality due to influenza: pandemic and peri-pandemic
000D63 (2011) Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada]Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age
001382 (2007) Michael J. Haber [États-Unis] ; Davis K. Shay [États-Unis] ; Xiaohong M. Davis [États-Unis] ; Rajan Patel [États-Unis] ; Xiaoping Jin [États-Unis] ; Eric Weintraub [États-Unis] ; Evan Orenstein [États-Unis] ; William W. Thompson [États-Unis]Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic
000369 (2016-11) Laurent Filleul ; Dany Bakoly Ranoaritiana ; Elsa Balleydier ; David Vandroux ; Clémence Ferlay ; Marie-Christine Jaffar-Bandjee ; Julien Jaubert ; Bénédicte Roquebert ; Bruno Lina [France] ; Martine Valette ; Bruno Hubert ; Sophie Larrieu ; Elise BrottetA major impact of the influenza seasonal epidemic on intensive care units, Réunion, April to August 2016
000421 (2016) April J. Cobos [États-Unis] ; Clinton G. Nelson [États-Unis] ; Megan Jehn [États-Unis] ; Cécile Viboud [États-Unis] ; Gerardo Chowell [États-Unis]Mortality and transmissibility patterns of the 1957 influenza pandemic in Maricopa County, Arizona
000E74 (2010) N. Ikonen [Finlande] ; M. Strengell ; L. Kinnunen ; P. Osterlund ; J. Pirhonen ; M. Broman ; I. Davidkin ; T. Ziegler ; I. JulkunenHigh frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.
001373 (2007) Fred Y. Aoki [Canada] ; Guy Boivin ; Noel RobertsInfluenza virus susceptibility and resistance to oseltamivir.
001587 (2005) Rajan Patel [États-Unis] ; Ira M. Longini ; M Elizabeth HalloranFinding optimal vaccination strategies for pandemic influenza using genetic algorithms.
001790 (2002) W. E. P. Beyer [Pays-Bas] ; A. M. Palache [Pays-Bas] ; J. C. De Jong [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas]Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis
001A53 (1998) Lone Simonsen [Géorgie (pays)] ; Matthew J. Clarke [Géorgie (pays)] ; Lawrence B. Schonberger [Géorgie (pays)] ; Nancy H. Arden [Géorgie (pays)] ; Nancy J. Cox [Géorgie (pays)] ; Keiji Fukuda [Géorgie (pays), États-Unis]Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution
002310 (1987) R. E. Hope-Simpson [Royaume-Uni] ; D. B. Golubev [Russie]A new concept of the epidemic process of influenza A virus
002531 (1984) R. E. Hope-SimpsonAge and secular distributions of virus-proven influenza patients in successive epidemics 1961–1976 in Cirencester: Epidemiological significance discussed
002871 (1979) M L Profeta ; D. De Vito ; M. Fasan[Serologic survey of human type A influenza virus infection following 10-year periods of prevalence of H3N2 strains].
002D92 (????) A N Na Khin ; L G Katorgina ; T N Kim ; I M Krotova ; G M Denisov ; N V Trusov ; V N Reznik[Regularities of formation in a general population of serum antibodies to previously circulated influenza A viruses].
002E18 (????) A N Na Khin ; S A Donina ; G D Petukhova ; E M Koren'Kov ; E M Doroshenko ; E P Grigor'Eva ; M A Suvorova ; L G Rudenko[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009].
000274 (2017) Gerardo Chowell ; Lone Simonsen ; Rodrigo Fuentes ; Jose Flores ; Mark A. Miller ; Cécile ViboudSevere mortality impact of the 1957 influenza pandemic in Chile
000305 (2017) Dennis E. Te Beest [Pays-Bas] ; Erwin De Bruin [Pays-Bas] ; Sandra Imholz [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Michiel Van Boven [Pays-Bas]Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)
000562 (2015) Cécile Viboud [États-Unis] ; Lone Simonsen [États-Unis, Danemark] ; Rodrigo Fuentes ; Jose Flores [Chili] ; Mark A. Miller [États-Unis] ; Gerardo Chowell [États-Unis]Global Mortality Impact of the 1957–1959 Influenza Pandemic
001513 (2006) Suzanne L. Epstein [États-Unis]Prior H1N1 Influenza Infection and Susceptibility of Cleveland Family Study Participants during the H2N2 Pandemic of 1957: An Experiment of Nature
001690 (2004) Ira M. Longini ; M. Elizabeth Halloran ; Azhar Nizam ; Yang YangContaining Pandemic Influenza with Antiviral Agents
002482 (1984) G I Karpukhin ; T L Popova ; L S Karpova ; L M Tsybalova ; G M Denisov[Antigenic anachronism of the influenza A(H2N2) viruses in Leningrad in 1980. I. The epidemiological and serological characteristics of the influenzal infection caused by A/Leningrad/80 (H2N2) viruses].
002E45 (????) Z. Nikolova ; L Ia Zakstel'Skaia ; R. Kotseva ; E V Molibog[Age profile of the antihemagglutinins and antineuraminidase antibodies in type A influenza (author's transl)].
000220 (2018) Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie MignotAutoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy
000522 (2015) Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
001243 (2008) R J Green [Afrique du Sud] ; C. Feldman ; B. Schoub ; G A Richards ; S A Madhi ; H J Zar ; U. Lalloo ; K. Klugman ; D. Phillips ; N A Cameron ; R R EggersInfluenza guideline for South Africa--update 2008.
001797 (2001) L R Yeolekar [Inde] ; P B Kulkarni ; M S Chadha ; B L RaoSeroepidemiology of influenza in Pune, India.
001C04 (1996) S. Chatterjee [Inde] ; K K Mukherjee ; M C Mondal ; M S ChakrabrortyA study of influenza A virus in the city of Calcutta, India, high lighting the strain prevalence.
002576 (1983) John R. La Montagne [États-Unis]Summary of a Workshop on Disease Mechanisms and Prospects for Prevention of Reye's Syndrome
002722 (1981) Arnold S. Monto [États-Unis] ; H. F. Maassab [États-Unis]SEROLOGIC RESPONSES TO NONPREVALENT INFLUENZA A VIRUSES DURING INTERCYCLIC PERIODS
002955 (1979) W. M. Marine ; J. E. ThomasAntigenic memory to influenza A viruses in man determined by monovalent vaccines.
000563 (2015) Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
000602 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
000691 (2014) Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000859 (2013) Matthew S. Miller [États-Unis] ; Thomas J. Gardner [États-Unis] ; Florian Krammer [États-Unis] ; Lauren C. Aguado [États-Unis] ; Domenico Tortorella [États-Unis] ; Christopher F. Basler [États-Unis] ; Peter Palese [États-Unis]Neutralizing antibodies against previously-encountered influenza virus strains increase over time: A longitudinal analysis
000D93 (2010) N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
001132 (2009) Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta SubbaraoA live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
001240 (2008) William Paul Glezen [États-Unis]Modifying clinical practices to manage influenza in children effectively.
001492 (2006) Monika Lindemann [Allemagne] ; Oliver Witzke ; Peter Lütkes ; Melanie Fiedler ; Ernst Kreuzfelder ; Thomas Philipp ; Michael Roggendorf ; Hans Grosse-WildeELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients.
001741 (2003) M. Aymard [France] ; M. Valette [France] ; J. Luciani [France]Burden of influenza in children: preliminary data from a pilot survey network on community diseases.
001A96 (1998) A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
002064 (1990) H. Závadová [République tchèque] ; E. Domorázková ; J. Skovránková ; M. Vodicková ; P. Ragac ; V. Vonka[Reactivity and immunologic activity of polyvalent split influenza vaccine in children].
002D90 (????) F I Polezhaev ; G N Budilovski ; L M Garmashova ; Iu R. Rome Ko-Gurko ; A Iu Egorov[Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
002E05 (????) V M Zhdanov ; A N Slepushkin ; L M Kupriashina ; V V Ritova ; L V Feklisova[Level of antibodies to influenza viruses A and B in the blood sera of children under 13].
000498 (2015) A V Lyapunov ; S I Kolesnikov ; M A Khasnatinov ; E L Manzarova ; I V Petrova ; V V Dolgikh ; G A Danchinova[Child and Adolescent Interepydemic Immunity to Influenza Viruses].
000561 (2015) Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
000833 (2013) Alexandru Coman [Roumanie] ; Daniel N. Maftei ; Whitney S. Krueger ; Gary L. Heil ; John A. Friary ; Razvan M. Chereches ; Emanuela Sirlincan ; Paul Bria ; Claudiu Dragnea ; Iosif Kasler ; Gregory C. GraySerological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers.
000A27 (2012) Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo IcardiPhase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
000B97 (2011) Guus F. Rimmelzwaan [Pays-Bas] ; Rogier Bodewes ; Albert D M E. OsterhausVaccination strategies to protect children against seasonal and pandemic influenza.
000C86 (2011) Chao Qiu ; Yang Huang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Di Tian ; Wanju Zhang ; Yunwen Hu ; Zhenghong Yuan ; Xiaoyan Zhang ; Jianqing XuBoosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine
000E24 (2010) Ana Clara Monsalvo [Argentine] ; Juan P. Batalle [Argentine] ; M. Florencia Lopez [Argentine] ; Jens C. Krause [États-Unis] ; Jennifer Klemenc [États-Unis] ; Johanna Zea [Argentine, États-Unis] ; Bernardo Maskin [Argentine] ; Jimena Bugna [Argentine] ; Carlos Rubinstein [Argentine] ; Leandro Aguilar [Argentine] ; Liliana Dalurzo [Argentine] ; Romina Libster [Argentine] ; Vilma Savy [Argentine] ; Elsa Baumeister [Argentine] ; Liliana Aguilar [Argentine] ; Graciela Cabral [Argentine] ; Julia Font [Argentine] ; Liliana Solari [Argentine] ; Kevin P. Weller [États-Unis] ; Joyce Johnson [États-Unis] ; Marcela Echavarria [Argentine] ; Kathryn M. Edwards [États-Unis] ; James D. Chappell [États-Unis] ; James E. Crowe [États-Unis] ; John V. Williams [États-Unis] ; Guillermina A. Melendi [Argentine, États-Unis] ; Fernando P. Polack [Argentine, États-Unis]Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
001081 (2009) Terho Heikkinen ; Ville PeltolaInfluenza vaccination of children.
001771 (2002) N. Hehme [Allemagne] ; H. Engelmann [Allemagne] ; W. Künzel [Allemagne] ; E. Neumeier [Allemagne] ; R. S Nger [Allemagne]Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines
001B22 (1997) K. Hashigucci ; S. Tamura ; T. Kurata ; H. Kamiya ; T. Ishidate[Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers].
001E68 (1993) Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis]Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge
002348 (1986) G. I. Alexandrova [Russie] ; G. N. Budilovsky [Russie] ; T. A. Koval [Russie] ; F. I. Polezhaev [Russie] ; L. M. Garmashova [Russie] ; Yu. Z. Ghendon [Russie] ; Y. R. Romanova [Russie] ; A. A. Smorodintsev [Russie]Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial
002487 (1984) A. N. Slepushkin ; V. V. Ritova ; L. V. Feklisova ; G. I. Fedorova ; N. P. Obrosova-Serova ; E. S. Safonova ; L. M. Kupryashina ; E. V. Molibog ; V. A. Slepushkin ; V. M. ZhdanovResults of a two-year study of humoral immunity to influenza A and B viruses in children under the age of 14 years in Moscow and its suburbs*
002779 (1980) A S Beare ; A P Kendal ; N J Cox ; C. ScholtissekHuman trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978.
002A41 (1977) R J Marttila ; P. Halonen ; U K RinneInfluenza virus antibodies in Parkinsonism. Comparison of postencephalic and idiopathic Parkinson patients and matched controls.
002A70 (1977) Colin Mclaren [États-Unis] ; Martha W. Verbonitz [États-Unis] ; Sylvester Daniel [États-Unis] ; George E. Grubbs [États-Unis] ; Francis A. Ennis [États-Unis]Effect of Priming Infection on Serologic Response to Whole and Subunit Influenza Virus Vaccines in Animals
002A78 (1977) Gary R. Noble [Géorgie (pays), États-Unis] ; Harold S. Kaye [Géorgie (pays)] ; Alan P. Kendal [Géorgie (pays)] ; Walter R. Dowdle [Géorgie (pays)]Age-Related Heterologous Antibody Responses to Influenza Virus Vaccination
002B01 (1976) J M GwaltneyThe use of live attenuated influenza vaccine ts-1(E) in man.
002D89 (????) N A Ivanova ; E B Grinbaum ; L Iu Taros ; T Ia Luzianina ; A A Smorodintsev[Serological foundation for the persisting circulation of influenza viruses A(HON1) and A(H2N2) among children].
002E26 (????) T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
002E51 (????) A Z Pljusnin ; S A Rozhkova ; O V Nolandt ; E A Bryantseva ; O K Kuznetsov ; F S NoskovMolecular hybridization with DNA-probes as a laboratory diagnostic test for influenza viruses.
000465 (2016) Sergio M. Qui Ones-Parra [Australie] ; E. Bridie Clemens [Australie] ; Zhongfang Wang [Australie] ; Hayley A. Croom [Australie] ; Lukasz Kedzierski [Australie] ; Jodie Mcvernon [Australie] ; Dhanasekaran Vijaykrishna [Singapour] ; Katherine Kedzierska [Australie]A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses
000A85 (2012) Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta SubbaraoAn open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000B46 (2012) Jens C. Krause [États-Unis] ; Tshidi Tsibane [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Chelsey J. Huffman [États-Unis] ; Randy Albrecht [États-Unis] ; David L. Blum [États-Unis] ; Irene Ramos [États-Unis] ; Ana Fernandez-Sesma [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Christopher F. Basler [États-Unis] ; James E. Jr Crowe [États-Unis]Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
000E85 (2010) Pierre Van Damme [Belgique] ; Robert Arnou ; Froukje Kafeja ; Anne Fiquet ; Patrick Richard ; Stéphane Thomas ; Gilles Meghlaoui ; Sandrine Isabelle Samson ; Emilio LedesmaEvaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.
001062 (2009) Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie]Pandemic Vaccine Preparedness—Have We Left Something Behind?
001280 (2008) Robert B. Belshe [États-Unis]An introduction to influenza: lessons from the past in epidemiology, prevention, and treatment.
001516 (2006) Edwin D. KilbourneInfluenza Immunity: New Insights from Old Studies
001660 (2004) N. Hehme [Allemagne] ; H. Engelmann ; W. Kuenzel ; E. Neumeier ; R. SaengerImmunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
001740 (2003) D. Ploin [France] ; S. Liberas [France] ; D. Thouvenot [France] ; A. Fouilhoux [France] ; Y. Gillet [France] ; A. Denis [France] ; F. Chapuis [France] ; B. Lina [France] ; D. Floret [France]Influenza burden in children newborn to eleven months of age in a pediatric emergency department during the peak of an influenza epidemic.
001974 (1999) Neuraminidase inhibitors for treatment of influenza A and B infections.
001B21 (1997) K. Matsumoto[Prevention and control of influenza infection in the elderly in Japan--special emphasis on high risk group patients].
002231 (1988) M. H. Pritchard [Royaume-Uni] ; N. Matthews [Royaume-Uni] ; Julia Munro [Royaume-Uni]ANTIBODIES TO INFLUENZA A IN A CLUSTER OF CHILDREN WITH JUVENILE CHRONIC ARTHRITIS
002282 (1987) K G Nicholson ; D A Tyrrell ; J S Oxford ; J. Wood ; G C Schild ; C W Potter ; R. Jennings ; R H Michaels ; G. AppleyardInfectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR.
002301 (1987) N. Masurel [Pays-Bas]Influenza A and B antibody status in Tanzania
002643 (1982) F I Polezhaev ; L M Garmashova ; T A Koval ; G P Taranova ; N V Topuriya ; G I AleksandrovaAttenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
002658 (1982) M. Rekart [États-Unis] ; K. Rupnik [États-Unis] ; T C. Cesario [États-Unis] ; J G Tilles [États-Unis]PREVALENCE OF HEMAGGLUTINATION INHIBITION ANTIBODY TO CURRENT STRAINS OF THE H3N2 AND H1N1 SUBTYPES OF INFLUENZA A VIRUS IN SERA COLLECTED FROM THE ELDERLY IN 1976
002885 (1979) D L Murray ; D T Imagawa ; D M Okada ; J W St GemeAntibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.
002D75 (????) T E Medvedeva ; Iu R. Romanova ; M I Gushchina ; L G Rudenko ; Iu Z. Gendon ; G I Aleksandrova ; A I Klimov[The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A].
002D78 (????) Iu A. Desheva ; G V Danini ; E P Grigor'Eva ; S A Donina ; I V Kiseleva ; A R Rekstin ; L A Ermakova ; V K Natsina ; V M Nikolaeva ; N I Lonskaia ; G A El'Shina ; V G Zhavoronkov ; V P Drinevski ; M K Erofeeva ; A N Na Khin ; L G Rudenko[The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children].
002D84 (????) E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
002E17 (????) A N Slepushkin ; V V Ritova ; G I Fedorova ; L V Feklisova ; N P Obrosova-Serova[Humoral immunity to influenza A and B viruses in the blood sera of children younger than 14 in 1981].
002E24 (????) I V Kiseleva ; A I Klimov ; E P Grigor'Eva ; N V Larionova ; G I Aleksandrova ; L G Rudenko[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
000025 (2019-09-20) Sylvie Behillil [France] ; Faten May [France] ; Slim Fourati [France] ; Charles-Edouard Luyt [France] ; Thomas Chicheportiche [France] ; Romain Sonneville [France] ; Yacine Tandjaoui-Lambiotte [France] ; Damien Roux [France] ; Laurent Guérin [France] ; Julien Mayaux [France] ; Eric Maury [France] ; Alexis Ferré [France] ; Jean-François Georger [France] ; Guillaume Voiriot [France] ; Vincent Enouf [France] ; Sylvie Van Der Werf [France] ; Armand Mekontso Dessap [France] ; Nicolas De Prost [France]Oseltamivir Resistance in Severe Influenza A(H1N1)pdm09 Pneumonia and Acute Respiratory Distress Syndrome: A French Multicenter Observational Cohort Study
000128 (2018-03) V. Busignies [France] ; G. Simon [France] ; G. Mollereau [France] ; O. Bourry [France] ; V. Mazel [France] ; Manuel Rosa-Calatrava [France] ; P. Tchoreloff [France]Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study
000160 (2018) Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000406 (2016) Wei Wang ; Esmeralda Alvarado-Facundo ; Qiong Chen ; Christine M. Anderson [États-Unis] ; Dorothy Scott [États-Unis] ; Russell Vassell ; Carol D. WeissSerum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.
000653 (2014) Simon E. Hufton [Royaume-Uni] ; Paul Risley [Royaume-Uni] ; Christina R. Ball [Royaume-Uni] ; Diane Major [Royaume-Uni] ; Othmar G. Engelhardt [Royaume-Uni] ; Stephen Poole [Royaume-Uni]The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
000674 (2014) Andrew J. Broadbent [États-Unis] ; Celia P. Santos [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; Janine Lu [États-Unis] ; Zhongying Chen [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [États-Unis]Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates
000962 (2013) P. Wutzler [Allemagne] ; M. Knuf [Allemagne]Influenza und Influenzaimpfstoffe für Kinder
000987 (2012) Hervé Pascalis [Réunion] ; Sarah Temmam [Réunion] ; Magali Turpin [Réunion] ; Olivier Rollot [France] ; Antoine Flahault [France] ; Fabrice Carrat [France] ; Xavier Lamballerie [France] ; Patrick Gérardin [Réunion] ; Koussay Dellagi [Réunion]Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: a cohort study in Reunion Island
000A21 (2012) Juergen A. Richt [États-Unis] ; Barry Rockx [Canada] ; Wenjun Ma [États-Unis] ; Friederike Feldmann [Canada] ; David Safronetz [Canada] ; Andrea Marzi [Canada] ; Darwyn Kobasa [Canada] ; James E. Strong [Canada] ; Lisa Kercher [États-Unis] ; Dan Long [États-Unis] ; Don Gardner [États-Unis] ; Douglas Brining [États-Unis] ; Heinz Feldmann [Canada]Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques
000C81 (2011) Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. KatzComparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
000D08 (2011) Gary J. Nabel [États-Unis] ; Chih-Jen Wei [États-Unis] ; Julie E. Ledgerwood [États-Unis]Vaccinate for the next H2N2 pandemic now
000D44 (2011) P D GriffithsEditorial: which influenza subtype should be added to the next vaccine?
000E31 (2010) Claudia Pappas [États-Unis] ; Karthik Viswanathan [États-Unis] ; Aarthi Chandrasekaran [États-Unis] ; Rahul Raman [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Ram Sasisekharan [États-Unis] ; Terrence M. Tumpey [États-Unis]Receptor Specificity and Transmission of H2N2 Subtype Viruses Isolated from the Pandemic of 1957

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021